ZYDUS LIFESCIENCES LTD.

NSE : ZYDUSLIFEBSE : 532321ISIN CODE : INE010B01027Industry : Pharmaceuticals & DrugsHouse : Cadila
BSE922.20-14.1 (-1.51 %)
PREV CLOSE ( ) 936.30
OPEN PRICE ( ) 929.30
BID PRICE (QTY) 921.40 (8)
OFFER PRICE (QTY) 921.95 (25)
VOLUME 31176
TODAY'S LOW / HIGH ( )913.25 933.00
52 WK LOW / HIGH ( )482.55 1031.3
NSE919.50-17.5 (-1.87 %)
PREV CLOSE( ) 937.00
OPEN PRICE ( ) 920.25
BID PRICE (QTY) 919.45 (1)
OFFER PRICE (QTY) 919.50 (28)
VOLUME 1018992
TODAY'S LOW / HIGH( ) 913.20 933.10
52 WK LOW / HIGH ( )484.95 1031.7
Peer Companies Price () Chg () Chg (%) EPS () TTM P/E Volume (000's) 1 Year Return (%)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.